Health Canada has provided positive feedback on Tetra Bio-Pharma’s clinical trial application to evaluate its drug candidate ARDS-003 in Covid-19 patients.
Tetra Bio-Pharma will be requesting a meeting with the U.S. Food and Drug Administration (FDA) to discuss the drug development program for its Orphan Drug candidate HCC011 ...